Skip to main content
Screener/Healthcare/Biotechnology

BCRX — BioCryst Pharmaceuticals, Inc.

NASDAQ
$7.49-0.14 (-1.90%)
Mid CapUnder $10HealthcareFastest GrowingLow BetaLow P/EMost ProfitableUndervalued
$6.23
$11.22
$7.38
$7.83
EPS (TTM)$1.20
P/E Ratio6.27
Dividend Yield—
Market Cap$2.16B
Volume1.38M
Prev Close$7.63
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$406.6M$245.8M$1.1297.6%60.5%
Q3 '25$159.4M$12.9M$0.0698.4%8.1%
Q2 '25$163.4M$5.1M$0.0298.3%3.1%
Q1 '25$145.5M$32K$0.0096.9%0.0%
Q4 '24$131.5M-$26.8M$-0.1395.3%-20.4%
Q3 '24$117.1M-$14.0M$-0.0797.2%-12.0%
Q2 '24$109.3M-$12.7M$-0.0698.4%-11.6%
Q1 '24$92.8M-$35.4M$-0.1798.6%-38.1%
Get Your Daily Market Recap